Table V.
Products associated with referred TRALI cases in Queensland, 1999–2019
| Products | All cases (n=48) | Antibody mediated TRALI (n=11) | Non-antibody mediated TRALI (n=10) | Antibody mediated possible TRALI (n=12) | Non-antibody mediated possible TRALI (n=6) | Uncategorised TRALI (n=9) |
|---|---|---|---|---|---|---|
| Red cells only | 18 (37.5%) | 1 (9.1%) | 7 (70.0%)a | 3 (33.3%) | 3 (50.0%) | 4 (44.4%) |
| Plasma products only | 10 (20.8%) | 4 (36.4%) | 1 (10.0%) | 1 (8.3%) | 2 (33.3%) | 2 (22.2%) |
| Platelets only | 4 (8.3%) | 2 (18.2%) | 0 (0%) | 2 (16.7%) | 0 (0%) | 0 (0%) |
| Multiple products | 16 (33.3%) | 4 (36.4%) | 2 (20.0%) | 6 (50.0%) | 1 (16.7%) | 3 (33.3%) |
| Red cell cases | 32 | 4 | 9 | 8 | 4 | 7 |
| Units | 80 | 11 | 18 | 28 | 8 | 15 |
| Mean age (days) | 19.3 | 16.2 | 16.7 | 17.7 | 18.0 | 28.0 |
| Mean adjusted age | 0.46 | 0.36 | 0.40 | 0.43 | 0.43 | 0.67 |
| Platelets cases | 18 | 5 | 2 | 8 | 1 | 2 |
| Units | 26 | 4 | 2 | 9 | 2 | 2 |
| Mean age (days) | 3.5 | 3.7 | 4.5 | 3.5 | 3.0 | 3.0 |
| Mean adjusted age | 0.70 | 0.74 | 0.9 | 0.67 | 0.60 | 0.6 |
| Plasma cases | 21 | 8 | 2 | 5 | 2 | 4 |
| Units | 75 | 25 | 3 | 22 | 5 | 20 |
| Mean age (days) | 43.6 | 24.5 | 130 | 63.6 | 29.2 | 37.1 |
| Mean adjusted age | 0.12 | 0.09 | 0.36 | 0.17 | 0.08 | 0.1 |
a
p-value <0.05 vs antibody mediated TRALI.